Clinical Trial

Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried

Name: Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried — clinical trial record (NCT07357545)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 3

View on ClinicalTrials.gov →

Summary

To evaluate the immunogenicity and safety of different post-exposure prophylaxis (PEP) schedules of Sinovac rabies vaccine, in comparison with a marked rabies vaccinein china, in subjects aged 10-60 years old.

Trial Details

NCT Number	NCT07357545
Lead Sponsor	Sinovac Biotech Co., Ltd
Conditions	Rabies (Healthy Volunteers)
Enrollment	2,040 participants
Start Date	2021-08-27
Primary Completion	2022-09-21 (estimated)
Study Completion	2023-06-21 (estimated)
Updated on ClinicalTrials.gov	2026-01-22